{"pmid":32478706,"title":"Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?","text":["Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?","The main characteristics and challenging symptoms of COVID-19, caused by the novel coronavirus SARS-CoV-2, are related to re-spiratory distress. Although most patients have mild symptoms such as fever, headache, cough, myalgia and anosmia, some develop acute respiratory distress syndrome, leading to death in many cases. Human coronavirus (CoVs) were responsible for two previ-ous worldwide outbreaks: Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV). Several reports of these outbreaks demonstrated that these diseases affected the central nervous system (CNS).[1] Thus, for the current COVID-19 pandemic, a crucial question arises: does CNS affection at least partially explain the respiratory distress commonly found in these patients?","MEDICC Rev","Machado-Curbelo, Calixto","32478706"],"abstract":["The main characteristics and challenging symptoms of COVID-19, caused by the novel coronavirus SARS-CoV-2, are related to re-spiratory distress. Although most patients have mild symptoms such as fever, headache, cough, myalgia and anosmia, some develop acute respiratory distress syndrome, leading to death in many cases. Human coronavirus (CoVs) were responsible for two previ-ous worldwide outbreaks: Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV). Several reports of these outbreaks demonstrated that these diseases affected the central nervous system (CNS).[1] Thus, for the current COVID-19 pandemic, a crucial question arises: does CNS affection at least partially explain the respiratory distress commonly found in these patients?"],"journal":"MEDICC Rev","authors":["Machado-Curbelo, Calixto"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478706","source":"PubMed","week":"202023|Jun 01 - Jun 07","topics":["Mechanism"],"weight":1,"_version_":1668532089492865024,"score":9.490897,"similar":[{"pmid":32399719,"title":"Involvement of the Nervous System in SARS-CoV-2 Infection.","text":["Involvement of the Nervous System in SARS-CoV-2 Infection.","As a severe and highly contagious infectious disease, coronavirus disease 2019 (COVID-19) has caused a global pandemic. Several case reports have demonstrated that the respiratory system is the main target in patients with COVID-19, but the disease is not limited to the respiratory system. Case analysis indicated that the nervous system can be invaded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and that 36.4% of COVID-19 patients had neurological symptoms. Importantly, the involvement of the CNS may be associated with poor prognosis and disease worsening. Here, we discussed the symptoms and evidence of nervous system involvement (directly and indirectly) caused by SARS-CoV-2 infection and possible mechanisms. CNS symptoms could be a potential indicator of poor prognosis; therefore, the prevention and treatment of CNS symptoms are also crucial for the recovery of COVID-19 patients.","Neurotox Res","Li, Hao","Xue, Qun","Xu, Xingshun","32399719"],"abstract":["As a severe and highly contagious infectious disease, coronavirus disease 2019 (COVID-19) has caused a global pandemic. Several case reports have demonstrated that the respiratory system is the main target in patients with COVID-19, but the disease is not limited to the respiratory system. Case analysis indicated that the nervous system can be invaded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and that 36.4% of COVID-19 patients had neurological symptoms. Importantly, the involvement of the CNS may be associated with poor prognosis and disease worsening. Here, we discussed the symptoms and evidence of nervous system involvement (directly and indirectly) caused by SARS-CoV-2 infection and possible mechanisms. CNS symptoms could be a potential indicator of poor prognosis; therefore, the prevention and treatment of CNS symptoms are also crucial for the recovery of COVID-19 patients."],"journal":"Neurotox Res","authors":["Li, Hao","Xue, Qun","Xu, Xingshun"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399719","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s12640-020-00219-8","keywords":["covid-19","central nervous system","infection","sars-cov-2"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1666865855036653569,"score":214.28708},{"pmid":32463395,"title":"The involvement of the central nervous system in patients with COVID-19.","text":["The involvement of the central nervous system in patients with COVID-19.","Coronaviruses disease (COVID-19) has caused major outbreaks. A novel variant, SARS-CoV-2, is responsible for COVID-19 pandemic. Clinical presentations and pathological mechanisms of COVID-19 are broad. The respiratory aspect of the disease has been extensively researched. Emerging studies point out the possibility of the central nervous system (CNS) involvement by COVID-19. Here, we discuss the current evidence for CNS involvement in COVID-19 and highlight that the high pathogenicity of SARS-CoV-2 might be due to its neuroinvasive potential.","Rev Neurosci","Saleki, Kiarash","Banazadeh, Mohammad","Saghazadeh, Amene","Rezaei, Nima","32463395"],"abstract":["Coronaviruses disease (COVID-19) has caused major outbreaks. A novel variant, SARS-CoV-2, is responsible for COVID-19 pandemic. Clinical presentations and pathological mechanisms of COVID-19 are broad. The respiratory aspect of the disease has been extensively researched. Emerging studies point out the possibility of the central nervous system (CNS) involvement by COVID-19. Here, we discuss the current evidence for CNS involvement in COVID-19 and highlight that the high pathogenicity of SARS-CoV-2 might be due to its neuroinvasive potential."],"journal":"Rev Neurosci","authors":["Saleki, Kiarash","Banazadeh, Mohammad","Saghazadeh, Amene","Rezaei, Nima"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463395","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1515/revneuro-2020-0026","keywords":["ace2","covid-19","sars-cov-2","anosmia","central nervous system (cns)","coronavirus"],"topics":["Mechanism"],"weight":1,"_version_":1668079521234944001,"score":204.45798},{"pmid":32470824,"title":"Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.","text":["Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.","INTRODUCTION: Neuropsychiatric manifestations of the coronavirus disease 2019 (COVID-19) have been described, including anosmia, ageusia, headache, paresthesia, encephalitis and encephalopathy. Little is known about the mechanisms by which the virus causes central nervous system (CNS) symptoms, and therefore little guidance is available regarding potential workup or management options. CASES: We present a series of four consecutive cases, seen by our psychiatry consultation service over a one-week period, each of which manifested delirium as a result of infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). DISCUSSION: The four cases highlighted here all occurred in older patients with premorbid evidence of cognitive decline. Unique features seen in multiple cases included rigidity, alogia, abulia, and elevated inflammatory markers. In all four cases, a change in mental status was the presenting symptom, and three of the four cases lacked significant respiratory symptoms. In addition to discussing unique features of the cases, we discuss possible pathophysiologic explanations for COVID-19 delirium. CONCLUSIONS: Delirium should be recognized as a potential feature of infection with SARS-CoV-2 and may be the only presenting symptom. Based on the high rates of delirium demonstrated in prior studies, hospitals should consider adding mental status changes to the list of testing criteria. Further research is needed to determine if delirium in COVID-19 represents a primary encephalopathy heralding invasion of the CNS by the virus, or a secondary encephalopathy related to systemic inflammatory response or other factors.","Gen Hosp Psychiatry","Beach, Scott R","Praschan, Nathan C","Hogan, Charlotte","Dotson, Samuel","Merideth, Flannery","Kontos, Nicholas","Fricchione, Gregory L","Smith, Felicia A","32470824"],"abstract":["INTRODUCTION: Neuropsychiatric manifestations of the coronavirus disease 2019 (COVID-19) have been described, including anosmia, ageusia, headache, paresthesia, encephalitis and encephalopathy. Little is known about the mechanisms by which the virus causes central nervous system (CNS) symptoms, and therefore little guidance is available regarding potential workup or management options. CASES: We present a series of four consecutive cases, seen by our psychiatry consultation service over a one-week period, each of which manifested delirium as a result of infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). DISCUSSION: The four cases highlighted here all occurred in older patients with premorbid evidence of cognitive decline. Unique features seen in multiple cases included rigidity, alogia, abulia, and elevated inflammatory markers. In all four cases, a change in mental status was the presenting symptom, and three of the four cases lacked significant respiratory symptoms. In addition to discussing unique features of the cases, we discuss possible pathophysiologic explanations for COVID-19 delirium. CONCLUSIONS: Delirium should be recognized as a potential feature of infection with SARS-CoV-2 and may be the only presenting symptom. Based on the high rates of delirium demonstrated in prior studies, hospitals should consider adding mental status changes to the list of testing criteria. Further research is needed to determine if delirium in COVID-19 represents a primary encephalopathy heralding invasion of the CNS by the virus, or a secondary encephalopathy related to systemic inflammatory response or other factors."],"journal":"Gen Hosp Psychiatry","authors":["Beach, Scott R","Praschan, Nathan C","Hogan, Charlotte","Dotson, Samuel","Merideth, Flannery","Kontos, Nicholas","Fricchione, Gregory L","Smith, Felicia A"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470824","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.genhosppsych.2020.05.008","keywords":["akinetic mutism","covid-19","delirium","encephalopathy","sars-cov-2"],"locations":["ageusia","headache","paresthesia","alogia","abulia"],"topics":["Case Report"],"weight":1,"_version_":1668167109957386240,"score":197.12471},{"pmid":32104915,"title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.","text":["The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.","Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic coronavirus named SARS-CoV-2 (previously known as 2019-nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS-CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID-19) with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. The most characteristic symptom of patients with COVID-19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID-19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS-CoV and SARS-CoV2, it remains to make clear whether the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure.","J Med Virol","Li, Yan-Chao","Bai, Wan-Zhu","Hashikawa, Tsutomu","32104915"],"abstract":["Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic coronavirus named SARS-CoV-2 (previously known as 2019-nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS-CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID-19) with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. The most characteristic symptom of patients with COVID-19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID-19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS-CoV and SARS-CoV2, it remains to make clear whether the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure."],"journal":"J Med Virol","authors":["Li, Yan-Chao","Bai, Wan-Zhu","Hashikawa, Tsutomu"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32104915","source":"PubMed","week":"20209|Feb 24 - Mar 01","doi":"10.1002/jmv.25728","keywords":["cell susceptibility","coronavirus","dissemination","nervous system"],"locations":["Wuhan","China","SARS-CoV"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490791788544,"score":185.69466},{"pmid":32299636,"pmcid":"PMC7136883","title":"Should we expect neurological symptoms in the SARS-CoV-2 epidemic?","text":["Should we expect neurological symptoms in the SARS-CoV-2 epidemic?","INTRODUCTION: There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS associated with neurological diseases. DEVELOPMENT: Neurological symptoms were rarely reported in the SARS-CoV and MERS-CoV epidemics, although isolated cases were described. There are also reports of cases of neurological symptoms associated with CoV-OC43 and CoV-229E infection. The presence of neurological lesions, especially demyelinating lesions in the mouse hepatitis virus model, may explain the mechanisms by which coronaviruses enter the CNS, particularly those related with the immune response. This may explain the presence of coronavirus in patients with multiple sclerosis. We review the specific characteristics of SARS-CoV-2 and address the question of whether the high number of cases may be associated with greater CNS involvement. CONCLUSION: Although neurological symptoms are not frequent in coronavirus epidemics, the high number of patients with SARS-CoV-2 infection may explain the presence of the virus in the CNS and increase the likelihood of early- or delayed-onset neurological symptoms. Follow-up of patients affected by the SARS-CoV-2 epidemic should include careful assessment of the CNS.","Neurologia","Matias-Guiu, J","Gomez-Pinedo, U","Montero-Escribano, P","Gomez-Iglesias, P","Porta-Etessam, J","Matias-Guiu, J A","32299636"],"abstract":["INTRODUCTION: There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS associated with neurological diseases. DEVELOPMENT: Neurological symptoms were rarely reported in the SARS-CoV and MERS-CoV epidemics, although isolated cases were described. There are also reports of cases of neurological symptoms associated with CoV-OC43 and CoV-229E infection. The presence of neurological lesions, especially demyelinating lesions in the mouse hepatitis virus model, may explain the mechanisms by which coronaviruses enter the CNS, particularly those related with the immune response. This may explain the presence of coronavirus in patients with multiple sclerosis. We review the specific characteristics of SARS-CoV-2 and address the question of whether the high number of cases may be associated with greater CNS involvement. CONCLUSION: Although neurological symptoms are not frequent in coronavirus epidemics, the high number of patients with SARS-CoV-2 infection may explain the presence of the virus in the CNS and increase the likelihood of early- or delayed-onset neurological symptoms. Follow-up of patients affected by the SARS-CoV-2 epidemic should include careful assessment of the CNS."],"journal":"Neurologia","authors":["Matias-Guiu, J","Gomez-Pinedo, U","Montero-Escribano, P","Gomez-Iglesias, P","Porta-Etessam, J","Matias-Guiu, J A"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299636","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.nrl.2020.03.001","keywords":["central nervous system","coronavirus","esclerosis multiple","mers-cov","mouse hepatitis virus","multiple sclerosis","neurological symptoms","sars-cov","sars-cov-2","sistema nervioso central","sintomas neurologicos","virus murino de la hepatitis"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494861312001,"score":184.24156}]}